Maternal serum activin-A at 30–33 weeks in the prediction of preeclampsia

By Lai Jonathan   Pinas Ana   Syngelaki Argyro   Poon Leona C. Y.   Nicolaides Kypros H.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 8, 2013-05 ,pp. : 733-737

Informa Healthcare

Access to resources Recommend Favorite

Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia

By Moore Andreea G.   Young Heather   Keller Jennifer M.   Ojo Linda R.   Yan Jing   Simas Tiffany A. Moore   Maynard Sharon E.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 12, 2012-12 ,pp. : 2651-2657

Informa Healthcare

Access to resources Recommend Favorite

Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia

By Parrish Marc   Griffin Meredith   Morris Racheal   Darby Marie   Owens Michelle Y.   Martin James N.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, Iss. 12, 2010-12 ,pp. : 1451-1455

Informa Healthcare

Access to resources Recommend Favorite

Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30–33 weeks in the prediction of preeclampsia

By Mosimann Beatrice   Wagner Marion   Birdir Cahit   Poon Leona C. Y.   Nicolaides Kypros H.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 8, 2013-05 ,pp. : 763-767

Informa Healthcare

Access to resources Recommend Favorite

Prediction and Prevention of Preeclampsia

By Briceno-Perez Carlos   Briceno-Sanabria Liliana   Vigil-De Gracia Paulino  

Hypertension in Pregnancy, Vol. 28, Iss. 2, 2009-05 ,pp. : 138-155

Informa Healthcare

Access to resources Recommend Favorite